massively parallel sequencing
Dovetail Genomics, CareDx Partner on HLA Genotyping for Transplant Matching
The firms will launch an early-access program for CareDx's NGS-based AlloSeq Tx 17 HLA typing assay, which incorporates Dovetail's LinkPrep NGS technology.
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.
Illumina, Devyser Diagnostics Ink IVD Development Agreement
The agreement will enable Sweden's Devyser to perform regulatory registrations of its NGS-based IVD tests on Illumina's MiSeqDx sequencer in the US and Europe.
A comparison for 144 solid tumor samples showed a "high degree of alignment" with FoundationOne CDx and better calling of CNAs than Illumina's TSO 500.
Thermo Fisher Scientific, Boehringer Ingelheim Partner on Companion Dx for Lung Cancer
The firms will develop multiple NGS-based companion diagnostic tests based on the Oncomine Dx Express Test and Oncomine Dx Target Test.
Oct 12, 2023
European Commission Orders Illumina to Divest Grail
Mar 30, 2021
FTC Moves to Block Illumina's $8B Grail Acquisition
Feb 25, 2021
Feb 24, 2021